Get the Stockscreener App
0.8082
2.63%
-0.0218
Pre-market:
.83
0.0218
+2.70%
Bioaffinity Technologies Inc stock is traded at $0.8082, with a volume of 225.74K.
It is down -2.63% in the last 24 hours and down -53.28% over the past month.
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
See More
Previous Close:
$0.83
Open:
$0.8334
24h Volume:
225.74K
Relative Volume:
0.34
Market Cap:
$5.08M
Revenue:
$5.66M
Net Income/Loss:
$-15.88M
P/E Ratio:
-0.0714
EPS:
-11.3134
Net Cash Flow:
$-10.93M
1W Performance:
+0.57%
1M Performance:
-53.28%
6M Performance:
-37.35%
1Y Performance:
-90.11%
1-Day Range:
$0.7823
$0.8343
1-Week Range:
$0.7823
$0.87
52-Week Range:
$0.693
$13.50
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Name
Bioaffinity Technologies Inc
Sector
Industry
Phone
210-698-5334
Address
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, IDXX, NTRA, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIAF
Bioaffinity Technologies Inc
|
0.8082 | 5.10M | 5.66M | -15.88M | -10.93M | -11.31 |
TMO
Thermo Fisher Scientific Inc
|
517.60 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
193.62 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
564.98 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
283.80 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
378.89 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Bioaffinity Technologies Inc Stock (BIAF) Latest News
bioAffinity Technologies Sees Record CyPath® Lung Test Sales, Expands Veteran Screening with Philips Partnership - Minichart
bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening - TradingView
CyPath Lung sales surge as bioAffinity (NASDAQ: BIAF) expands pipeline - Stock Titan
bioAffinity Technologies Company Profile & Introduction - Moomoo
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
bioAffinity Technologies Inc (BIAF) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - BioSpace
bioAffinity Technologies reports skin cancer siRNA preclinical results - grafa.com
bioAffinity to present skin cancer treatment research - Investing.com
bioAffinity to present skin cancer treatment research By Investing.com - Investing.com South Africa
BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill
BioAffinity Technologies Closes $3.2 Million Public Offering - Moomoo
bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts - TradingView
bioAffinity Technologies Inc (BIAFW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale - Stock Titan
bioAffinity Technologies Announces Closing of $3.2 Million Offering - Quantisnow
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies closes $3.2M public offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies closes $3.2M public offering - Investing.com
BIOAFFINITY TECHNOLOGIES ANNOUNCES CLOSING OF $3.2 MILLION OFFERING - Moomoo
bioAffinity Technologies Inc (BIAFW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies Inc (BIAFW) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAFW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAFW) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants - Stock Titan
bioAffinity Technologies Inc (BIAF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
bioAffinity Technologies Inc (BIAF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13% - Moomoo
bioAffinity Technologies (BIAF) Slides Nearly 12% – Testing Key Support at $0.79Impulse Wave - newsline.com
bioAffinity Technologies Inc (BIAF) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies Inc (BIAF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies prices $3.2M public offering By Investing.com - Investing.com India
bioAffinity Technologies prices $3.2M public offering - Investing.com UK
WallachBeth Capital Announces Pricing of bioAffinity Technologie - GuruFocus
bioAffinity Technologies closes $3.2 million public offering - scanx.trade
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies Announces Pricing of $3.2 Million Offering - Business Wire
bioAffinity Technologies Inc (BIAFW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAFW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan
bioAffinity (BIAF) S-1/A adds placement agency pact and warrant forms - Stock Titan
bioAffinity to participate in veterans lung health webinar By Investing.com - Investing.com Australia
bioAffinity to participate in veterans lung health webinar - Investing.com
bioAffinity Technologies to host July 21 webinar on veteran lung screening with Philips and 4DMedical - TradingView
Veteran lung health webinar from bioAffinity (BIAF) spotlights CyPath® Lung - Stock Titan
Bioaffinity Technologies Inc Stock (BIAF) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
2.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):